# Placebos and Blinding in Randomized Controlled Cancer Clinical Trials for Drug and Biological Products Guidance for Industry - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/placebos-and-blinding-in-randomized-controlled-cancer-clinical-trials-for-drug-and-biological-products-guidance-for-industry/f88966dd-4dae-4b98-ae6e-e21b153bfb43 > FDA guidance document: Placebos and Blinding in Randomized Controlled Cancer Clinical Trials for Drug and Biological Products Guidance for Industry. Issue date: August 29, 2019. Get complete insights and analysis. --- ## Details - Title: Placebos and Blinding in Randomized Controlled Cancer Clinical Trials for Drug and Biological Products Guidance for Industry - Communication Type: Guidance Document - Product Type: biologics - Office Name: Center for Drug Evaluation and Research - Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c - Issue Date: 2019-08-29 - Last Changed: 2020-05-15 - Docket Number: FDA-2018-D-3092 ## Related Documents - [Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products](https://www.globalkeysolutions.net/guidances/guidance-document/adjusting-for-covariates-in-randomized-clinical-trials-for-drugs-and-biological-products/f58b2adc-b92a-4458-b269-5346d25a8a39) - [Cancer Clinical Trial Eligibility Criteria: Available Therapy in Non-Curative Settings: Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/cancer-clinical-trial-eligibility-criteria-available-therapy-in-non-curative-settings-guidance-for-industry/d21a3c21-c758-4f3f-b215-edfe13aa09a3) - [Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products: Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/enrichment-strategies-for-clinical-trials-to-support-approval-of-human-drugs-and-biological-products-guidance-for-industry/7a080f34-cb3a-4789-b96a-a16fd0b0e9ef)